SE9601598L - Nytt förfarande - Google Patents

Nytt förfarande

Info

Publication number
SE9601598L
SE9601598L SE9601598A SE9601598A SE9601598L SE 9601598 L SE9601598 L SE 9601598L SE 9601598 A SE9601598 A SE 9601598A SE 9601598 A SE9601598 A SE 9601598A SE 9601598 L SE9601598 L SE 9601598L
Authority
SE
Sweden
Prior art keywords
pct
sec
formula
date
magnesium source
Prior art date
Application number
SE9601598A
Other languages
English (en)
Other versions
SE9601598D0 (sv
SE508669C2 (sv
Inventor
Jan-Aake Hoegberg
Panagiotis Ioannidis
Anders Mattson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20402358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9601598(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9601598A priority Critical patent/SE508669C2/sv
Publication of SE9601598D0 publication Critical patent/SE9601598D0/sv
Priority to SA97170759A priority patent/SA97170759B1/ar
Priority to TW086104766A priority patent/TW420676B/zh
Priority to ZA9703153A priority patent/ZA973153B/xx
Priority to ARP970101488A priority patent/AR006640A1/es
Priority to TNTNSN97068A priority patent/TNSN97068A1/fr
Priority to MA24558A priority patent/MA24143A1/fr
Priority to DZ970056A priority patent/DZ2209A1/fr
Priority to HR970210A priority patent/HRP970210B1/xx
Priority to TR1998/02156T priority patent/TR199802156T2/xx
Priority to UA98105319A priority patent/UA51699C2/uk
Priority to EG32297A priority patent/EG23874A/xx
Priority to DE69714987T priority patent/DE69714987T2/de
Priority to EP97921045A priority patent/EP0897386B1/en
Priority to SK1407-98A priority patent/SK282752B6/sk
Priority to RU98121016/04A priority patent/RU2163238C2/ru
Priority to US08/860,825 priority patent/US6124464A/en
Priority to HU9901798A priority patent/HUP9901798A3/hu
Priority to IDP971342A priority patent/ID16685A/id
Priority to IL12671697A priority patent/IL126716A/xx
Priority to BR9708829A priority patent/BR9708829A/pt
Priority to AT97921045T priority patent/ATE222904T1/de
Priority to SI9730402T priority patent/SI0897386T1/xx
Priority to PT97921045T priority patent/PT897386E/pt
Priority to CZ19983398A priority patent/CZ295067B6/cs
Priority to KR10-1998-0708556A priority patent/KR100468331B1/ko
Priority to PL97329683A priority patent/PL188824B1/pl
Priority to NZ332154A priority patent/NZ332154A/en
Priority to CN97194114A priority patent/CN1100776C/zh
Priority to AU27193/97A priority patent/AU711345C/en
Priority to PCT/SE1997/000674 priority patent/WO1997041114A1/en
Priority to HK99102051.4A priority patent/HK1016978B/en
Priority to DK97921045T priority patent/DK0897386T3/da
Priority to EE9800363A priority patent/EE03485B1/xx
Priority to CA002251636A priority patent/CA2251636C/en
Priority to JP53879697A priority patent/JP4233115B2/ja
Priority to ES97921045T priority patent/ES2180981T3/es
Priority to MYPI97001748A priority patent/MY119011A/en
Publication of SE9601598L publication Critical patent/SE9601598L/sv
Priority to YUP-448/98A priority patent/RS49718B/sr
Priority to IS4872A priority patent/IS1984B/is
Priority to NO19984903A priority patent/NO318850B1/no
Publication of SE508669C2 publication Critical patent/SE508669C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9601598A 1996-04-26 1996-04-26 Nytt förfarande SE508669C2 (sv)

Priority Applications (41)

Application Number Priority Date Filing Date Title
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande
SA97170759A SA97170759B1 (ar) 1996-04-26 1997-03-29 عملية لتحضير ملح ماغنيسيوم لمركب سلفنيل حلقي غير متجانس sulfinyl heterocyclic به استبدال
TW086104766A TW420676B (en) 1996-04-26 1997-04-14 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
ZA9703153A ZA973153B (en) 1996-04-26 1997-04-14 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle.
ARP970101488A AR006640A1 (es) 1996-04-26 1997-04-14 Procedimiento para la preparacion de una sal de magnesio de un sulfinil-heterociclo substituido
TNTNSN97068A TNSN97068A1 (fr) 1996-04-26 1997-04-15 Procede pour la preparation d'un sel de magnesium d'un heterocycle sulfinyle substitue
MA24558A MA24143A1 (fr) 1996-04-26 1997-04-17 Procede pour la preparation d'un sel de magnesium d'un heterocycle sulfinyle substitue.
DZ970056A DZ2209A1 (fr) 1996-04-26 1997-04-20 Procédé pour la préparation d'un sel de magnésium d'un hétérocycle sulfinyle substitué.
HR970210A HRP970210B1 (en) 1996-04-26 1997-04-21 Process for the preparation of magnesium salt of a substituted sulphinil heterocycle
JP53879697A JP4233115B2 (ja) 1996-04-26 1997-04-22 置換スルフィニル複素環式化合物のマグネシウム塩の製造法
ES97921045T ES2180981T3 (es) 1996-04-26 1997-04-22 Procedimiento para la preparacion de una sal de magnesio de un heterociclo de sulfinilo sustituido.
IL12671697A IL126716A (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
PL97329683A PL188824B1 (pl) 1996-04-26 1997-04-22 Sposób wytwarzania soli magnezowych podstawionychzwiązków sulfinyloheterocyklicznych
EG32297A EG23874A (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt ofa substituted sulphinyle heterocycle
DE69714987T DE69714987T2 (de) 1996-04-26 1997-04-22 Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus
EP97921045A EP0897386B1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
SK1407-98A SK282752B6 (sk) 1996-04-26 1997-04-22 Spôsob prípravy horečnatej soli substituovanej sulfinylovej heterocyklickej zlúčeniny
RU98121016/04A RU2163238C2 (ru) 1996-04-26 1997-04-22 Способ получения магниевой соли замещенного сульфинил-гетероциклического соединения
US08/860,825 US6124464A (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulfinyl heterocycle
HU9901798A HUP9901798A3 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
IDP971342A ID16685A (id) 1996-04-26 1997-04-22 Proses pembuatan garam magnesium sulfinil heterolingkar tersubstitusi
TR1998/02156T TR199802156T2 (xx) 1996-04-26 1997-04-22 �kameli s�lfinil heteroksiklilin magnezyum tuzunun haz�rlanmas� i�lemi.
BR9708829A BR9708829A (pt) 1996-04-26 1997-04-22 Processo para a preparação de um sal de magnesio de um composto heterociclico sulfinil substituido contendo uma porção imidazol sal de magnesio e composição farmaceutica
AT97921045T ATE222904T1 (de) 1996-04-26 1997-04-22 Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus
SI9730402T SI0897386T1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
PT97921045T PT897386E (pt) 1996-04-26 1997-04-22 Processo para a preparacao de um sal de magnesio de um heterociclo substituido com sulfinilo
CZ19983398A CZ295067B6 (cs) 1996-04-26 1997-04-22 Způsob přípravy hořečnaté soli substituované sulfinylheterocyklické sloučeniny
KR10-1998-0708556A KR100468331B1 (ko) 1996-04-26 1997-04-22 치환된술피닐헤테로사이클의마그네슘염의제조방법
UA98105319A UA51699C2 (uk) 1996-04-26 1997-04-22 Спосіб одержання магнієвої солі заміщеного сульфінілом гетероциклу
NZ332154A NZ332154A (en) 1996-04-26 1997-04-22 Process for the production of a magnesium salt of a substituted sulphinyl benzimidazole
CN97194114A CN1100776C (zh) 1996-04-26 1997-04-22 制备取代亚磺酰基杂环镁盐的方法
AU27193/97A AU711345C (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
PCT/SE1997/000674 WO1997041114A1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
HK99102051.4A HK1016978B (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
DK97921045T DK0897386T3 (da) 1996-04-26 1997-04-22 Fremgangsmåde til fremstilling af et magnesiumsalt af en substitueret sulfinylheterocyklus
EE9800363A EE03485B1 (et) 1996-04-26 1997-04-22 Protsess asendatud sulfinüülheterotsükli magneesiumisoola valmistamiseks
CA002251636A CA2251636C (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
MYPI97001748A MY119011A (en) 1996-04-26 1997-04-23 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
YUP-448/98A RS49718B (sr) 1996-04-26 1998-10-14 Postupak dobijanja magnezijumove soli supstituisanog heterocikličnog sulfinila
IS4872A IS1984B (is) 1996-04-26 1998-10-19 Aðferð til að framleiða magnesíumsalt af útskiptum súlfínýl-heteróhring
NO19984903A NO318850B1 (no) 1996-04-26 1998-10-21 Fremgangsmate for fremstilling av et magnesiumsalt av en substituert sulfinylheterocyklisk forbindelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande

Publications (3)

Publication Number Publication Date
SE9601598D0 SE9601598D0 (sv) 1996-04-26
SE9601598L true SE9601598L (sv) 1997-10-27
SE508669C2 SE508669C2 (sv) 1998-10-26

Family

ID=20402358

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande

Country Status (39)

Country Link
US (1) US6124464A (sv)
EP (1) EP0897386B1 (sv)
JP (1) JP4233115B2 (sv)
KR (1) KR100468331B1 (sv)
CN (1) CN1100776C (sv)
AR (1) AR006640A1 (sv)
AT (1) ATE222904T1 (sv)
BR (1) BR9708829A (sv)
CA (1) CA2251636C (sv)
CZ (1) CZ295067B6 (sv)
DE (1) DE69714987T2 (sv)
DK (1) DK0897386T3 (sv)
DZ (1) DZ2209A1 (sv)
EE (1) EE03485B1 (sv)
EG (1) EG23874A (sv)
ES (1) ES2180981T3 (sv)
HR (1) HRP970210B1 (sv)
HU (1) HUP9901798A3 (sv)
ID (1) ID16685A (sv)
IL (1) IL126716A (sv)
IS (1) IS1984B (sv)
MA (1) MA24143A1 (sv)
MY (1) MY119011A (sv)
NO (1) NO318850B1 (sv)
NZ (1) NZ332154A (sv)
PL (1) PL188824B1 (sv)
PT (1) PT897386E (sv)
RS (1) RS49718B (sv)
RU (1) RU2163238C2 (sv)
SA (1) SA97170759B1 (sv)
SE (1) SE508669C2 (sv)
SI (1) SI0897386T1 (sv)
SK (1) SK282752B6 (sv)
TN (1) TNSN97068A1 (sv)
TR (1) TR199802156T2 (sv)
TW (1) TW420676B (sv)
UA (1) UA51699C2 (sv)
WO (1) WO1997041114A1 (sv)
ZA (1) ZA973153B (sv)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
US6403616B1 (en) * 1998-11-18 2002-06-11 Astrazeneca Ab Chemical process and pharmaceutical formulation
CA2290893C (en) 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
AU2001276721A1 (en) * 2000-08-04 2002-02-18 Takeda Chemical Industries Ltd. Salts of benzimidazole compound and use thereof
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
ES2286408T3 (es) * 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
EA200500673A1 (ru) * 2002-10-22 2005-12-29 Рэнбакси Лабораториз Лимитед Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
US20040242642A1 (en) * 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
EP1572680A2 (en) * 2002-12-19 2005-09-14 Eva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
US20060247277A1 (en) * 2003-02-28 2006-11-02 Yatendra Kumar Polymorphs of s-omeprazole
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302382D0 (sv) * 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
ITMI20031813A1 (it) * 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US20080139623A1 (en) 2006-06-12 2008-06-12 Lilach Hedvati Amorphous and crystalline forms of pantoprazole magnesium salt
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
JP2010519284A (ja) 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法
US8106210B2 (en) * 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
EP2426111A1 (en) 2010-08-09 2012-03-07 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
CN103467453A (zh) * 2013-09-13 2013-12-25 上海海虹实业(集团)巢湖今辰药业有限公司 一种奥美拉唑镁原料药制备方法
CN106397399A (zh) * 2015-07-29 2017-02-15 陕西合成药业股份有限公司 一种泮托拉唑镁的精制方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
IL76837A0 (en) * 1984-10-31 1986-02-28 Byk Gulden Lomberg Chem Fab Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
FI861772L (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
FI864138A7 (fi) * 1985-10-16 1987-04-17 Fisons Plc Heterocykliska blandningar.
DD290192A5 (de) * 1986-11-13 1991-05-23 Eisai Co. Ltd,Jp Pyridinderivat mit antiulzeroeser wirkung
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
WO1989000566A1 (fr) * 1987-07-21 1989-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Composes de pyridine et leurs utilisations en medecine
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
KR950701921A (ko) * 1992-06-01 1995-05-17 고야 다다시 피리딘 화합물 및 이의 제약학적 용도(pyridine compound and medicinal use thereof)
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5374730A (en) * 1993-11-04 1994-12-20 Torcan Chemical Ltd. Preparation of omeprazole and lansoprazole
DK1078628T3 (da) * 1994-07-08 2009-02-23 Astrazeneca Ab Tabletteret flerenhedsdoseringsform

Also Published As

Publication number Publication date
CA2251636C (en) 2001-04-10
TNSN97068A1 (fr) 1999-12-31
DE69714987D1 (de) 2002-10-02
SE9601598D0 (sv) 1996-04-26
TW420676B (en) 2001-02-01
DE69714987T2 (de) 2003-04-30
UA51699C2 (uk) 2002-12-16
EE9800363A (et) 1999-04-15
ZA973153B (en) 1997-10-27
HRP970210A2 (en) 1998-04-30
JP2000509067A (ja) 2000-07-18
HK1016978A1 (en) 1999-11-12
AU2719397A (en) 1997-11-19
DK0897386T3 (da) 2002-10-28
SE508669C2 (sv) 1998-10-26
AR006640A1 (es) 1999-09-08
JP4233115B2 (ja) 2009-03-04
MY119011A (en) 2005-03-31
DZ2209A1 (fr) 2002-12-03
KR20000065018A (ko) 2000-11-06
RS49718B (sr) 2007-12-31
AU711345B2 (en) 1999-10-14
NO984903L (no) 1998-10-21
HUP9901798A2 (hu) 2000-04-28
ID16685A (id) 1997-10-30
RU2163238C2 (ru) 2001-02-20
TR199802156T2 (xx) 1999-02-22
CA2251636A1 (en) 1997-11-06
EP0897386A1 (en) 1999-02-24
PT897386E (pt) 2002-12-31
CN1100776C (zh) 2003-02-05
IS4872A (is) 1998-10-19
SA97170759B1 (ar) 2006-09-25
NZ332154A (en) 2002-03-01
NO984903D0 (no) 1998-10-21
ES2180981T3 (es) 2003-02-16
SK282752B6 (sk) 2002-12-03
SK140798A3 (en) 1999-04-13
BR9708829A (pt) 1999-08-03
PL188824B1 (pl) 2005-04-29
PL329683A1 (en) 1999-04-12
MA24143A1 (fr) 1997-12-31
NO318850B1 (no) 2005-05-18
KR100468331B1 (ko) 2005-03-16
EE03485B1 (et) 2001-08-15
HUP9901798A3 (en) 2003-02-28
EP0897386B1 (en) 2002-08-28
SI0897386T1 (en) 2002-12-31
CZ295067B6 (cs) 2005-05-18
IL126716A (en) 2003-10-31
ATE222904T1 (de) 2002-09-15
US6124464A (en) 2000-09-26
EG23874A (en) 2007-11-27
CN1216989A (zh) 1999-05-19
WO1997041114A1 (en) 1997-11-06
YU44898A (sh) 1999-07-28
CZ339898A3 (cs) 1999-03-17
HRP970210B1 (en) 2002-06-30
IL126716A0 (en) 1999-08-17
IS1984B (is) 2005-02-15

Similar Documents

Publication Publication Date Title
SE9601598D0 (sv) New process
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
DE69723869D1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
BG105925A (en) Novel tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
AU1120599A (en) New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
SE7906722L (sv) Merkaptoacylderivat av substituerade proliner
ZA959451B (en) 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
EA200200774A1 (ru) Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции
DE69332718D1 (de) Enantiomere von carbazolderivaten als 5-ht1-ähnliche agonisten
YU75101A (sh) Supstituisani biciklični heterocikli, postupak njihove izrade i njihova upotreba kao antigojaznih i hipoholesterolemijskih agenasa
HU9501585D0 (en) Azoxycyanobenzene-derivatives, process for their preparation, fungicidal compositions containing them
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
GB9405492D0 (en) Chemical compounds
PT823909E (pt) Nova quimica heterociclica
DE59304311D1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
DE59712632D1 (de) Verfahren zur herstellung von 3-pyrrolin-2-carbonsäure-derivaten
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
DE68902627D1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
IL109728A0 (en) Indoles
ATE35538T1 (de) (substituierte phenyl)-5-oxo-2pyrrolidinpropions|uren, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
ATE35546T1 (de) 1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung.
DE69838717D1 (de) Verfahren zur herstellung von imidazolonen
EP0300850A3 (en) 1-arylsulfonyl-1,5-dihydro 2h-pyrrol-2-one derivatives, intermediates and process for their preparation, their use as medicines and compositions containing them
NO954070L (no) Fremgangsmåte for fremstilling av

Legal Events

Date Code Title Description
NUG Patent has lapsed